Telesis Bio
TBIOTelesis Bio is transforming how biology is built by providing automated, in-lab DNA and mRNA synthesis solutions. The company's core technology, including the Gibson Assembly method and the Gibson SOLA enzymatic synthesis platform, empowers researchers to accelerate discovery timelines by up to 93% compared to traditional outsourcing. With a focus on therapeutic applications and a commitment to biosecurity, Telesis Bio serves a global customer base from its San Diego headquarters, enabling faster iteration and greater control in R&D pipelines.
TBIO · Stock Price
Historical price data
AI Company Overview
Telesis Bio is transforming how biology is built by providing automated, in-lab DNA and mRNA synthesis solutions. The company's core technology, including the Gibson Assembly method and the Gibson SOLA enzymatic synthesis platform, empowers researchers to accelerate discovery timelines by up to 93% compared to traditional outsourcing. With a focus on therapeutic applications and a commitment to biosecurity, Telesis Bio serves a global customer base from its San Diego headquarters, enabling faster iteration and greater control in R&D pipelines.
Technology Platform
The Gibson SOLA platform is an automated, enzymatic DNA and mRNA synthesis system that builds genetic material in blocks from oligonucleotides, enabling high-fidelity, on-demand production directly in the research lab.
Opportunities
Risk Factors
Competitive Landscape
Main competitors include large gene synthesis service providers (Twist Bioscience, GenScript) and newer enzymatic synthesis startups (DNA Script, Molecular Assemblies). Telesis Bio differentiates with its fully automated, integrated Gibson SOLA platform and its legacy in Gibson Assembly chemistry.